Cargando…

Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsaid, Afaf, Samir eid, Omnia, Said, Samy B., Zahran, Rasha F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523625/
https://www.ncbi.nlm.nih.gov/pubmed/34661767
http://dx.doi.org/10.1186/s43141-021-00260-w
_version_ 1784585334339665920
author Elsaid, Afaf
Samir eid, Omnia
Said, Samy B.
Zahran, Rasha F.
author_facet Elsaid, Afaf
Samir eid, Omnia
Said, Samy B.
Zahran, Rasha F.
author_sort Elsaid, Afaf
collection PubMed
description BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and SOD2 Val16Ala (rs4880) gene polymorphisms within ESRD Egyptian patients. METHODS: This work was conducted on 100 ESRD and 16 CKD Egyptian patients who were compared to 100 healthy controls. DNA was genotyped for these variants using the (T-ARMS-PCR) technique. RESULTS: ESRD patients showed a significant association of the genotype of NOS3 gene polymorphism compared with healthy controls (P = 0.032). In the contrast, the present study revealed that no statistically significant differences were found among the CKD, ESRD, and control groups as regards the SOD2 genotypes (P = 0.064). CONCLUSIONS: Our findings indicated a significant association between NOS3 (rs 2070744) gene polymorphism and increased risk of ESRD and CKD among Egyptian patients.
format Online
Article
Text
id pubmed-8523625
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85236252021-10-27 Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients Elsaid, Afaf Samir eid, Omnia Said, Samy B. Zahran, Rasha F. J Genet Eng Biotechnol Research BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and SOD2 Val16Ala (rs4880) gene polymorphisms within ESRD Egyptian patients. METHODS: This work was conducted on 100 ESRD and 16 CKD Egyptian patients who were compared to 100 healthy controls. DNA was genotyped for these variants using the (T-ARMS-PCR) technique. RESULTS: ESRD patients showed a significant association of the genotype of NOS3 gene polymorphism compared with healthy controls (P = 0.032). In the contrast, the present study revealed that no statistically significant differences were found among the CKD, ESRD, and control groups as regards the SOD2 genotypes (P = 0.064). CONCLUSIONS: Our findings indicated a significant association between NOS3 (rs 2070744) gene polymorphism and increased risk of ESRD and CKD among Egyptian patients. Springer Berlin Heidelberg 2021-10-18 /pmc/articles/PMC8523625/ /pubmed/34661767 http://dx.doi.org/10.1186/s43141-021-00260-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Elsaid, Afaf
Samir eid, Omnia
Said, Samy B.
Zahran, Rasha F.
Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title_full Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title_fullStr Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title_full_unstemmed Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title_short Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
title_sort association of nos3 (rs 2070744) and sod2val16ala (rs4880) gene polymorphisms with increased risk of esrd among egyptian patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523625/
https://www.ncbi.nlm.nih.gov/pubmed/34661767
http://dx.doi.org/10.1186/s43141-021-00260-w
work_keys_str_mv AT elsaidafaf associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients
AT samireidomnia associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients
AT saidsamyb associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients
AT zahranrashaf associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients